Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study
COVID-19 disproportionately affects patients with medical comorbidities such as cardiovascular disease (CVD). Patients with CVD are widely prescribed 3-hydroxy-3-methyl-glutayl-CoA (HMG-CoA) reductase inhibitors (statins), a class of lipid-lowering medications known for their pleiotropic anti-inflam...
Main Authors: | Sophia L. Song, Sarah B. Hays, Constance E. Panton, Evangelia K. Mylona, Markos Kalligeros, Fadi Shehadeh, Eleftherios Mylonakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/9/9/759 |
Similar Items
-
Statins in clinical medicine
by: Swiss Medical Weekly
Published: (2011-11-01) -
Are statins toxic or safe for kidney diseases? An updated mini-review study
by: Shadi Botshekan, et al.
Published: (2020-10-01) -
The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
by: Huanbiao Mo, et al.
Published: (2019-01-01) -
Statins and its Effects on Lipids and Glycemic Status: A Quasi-Experimental Study
by: Sikandar Hayat Khan, et al.
Published: (2024-04-01) -
Association of Statin Therapy with Functional Outcomes and Survival in Intracerebral and Subarachnoid Hemorrhage
by: Bahadar S. Srichawla, et al.
Published: (2025-02-01)